I3 Verticals, Inc. · NASDAQ:IIIV
I3 Verticals — Q3 2026 Earnings Presentation
10 slides from I3 Verticals's earnings presentation, Aug 7, 2026
Slide 1: Q3 Fiscal Year 2026 Supplemental Information
Q3 FISCAL YEAR 2026 Supplemental Information 1
Slide 2: Revenue Composition
Revenue Composition(1) ($ in thousands) Quarter Ended March 31, December 31, September March 31, December 31, September June 30, 2026 2026 2025 30, 2025 June 30, 2025 2025 2024 30, 2024 June 30, 2024 Recurring revenue SaaS(2) $ 12,798 $ 12,658 $ 10,959 $ 10,375 $ 9,299 $ 9,209 $ 8,812 $ 8,331 $ 7,51
Slide 3: Revenue Composition Footnotes
Revenue Composition 1.) As a result of the sale of our merchant services business (the "Merchant Services Business"), which was completed on September 20, 2024, and the sale of our Healthcare revenue cycle management business (the "Healthcare RCM Business"), which was completed on May 5, 2025, the h
Slide 4: Q3 Fiscal 2026 GAAP Measures; Use of Non-GAAP Financial Measures
Q3 Fiscal 2026 GAAP Measures; Use of Non-GAAP Financial Measures The following is our income (loss) from operations for the current and prior year quarters calculated in accordance with GAAP and presented for continuing operations only. ($ in thousands) Three Months Ended March 31, December 31, Sept
Slide 5: Quarterly Performance
Quarterly Performance ($ in thousands) Three Months Ended December 31, September 30, December 31, June 30, 2026 March 31, 2026 2025 2025 June 30, 2025 March 31, 2025 2024 Revenue from continuing operations $ 53,067 $ 57,518 $ 52,671 $ 54,901 $ 51,901 $ 54,135 $ 52,221 Recurring cash costs of service
Slide 6: Non-GAAP Financial Measures
Reconciliation of Non-GAAP Financial Measures(1) The reconciliation of our net income (loss) from continuing operations attributable to i3 Verticals, Inc. to non-GAAP adjusted income before taxes from continuing operations, non-GAAP adjusted net income from continuing operations and non-GAAP adjuste
Slide 7: Non-GAAP Financial Measures Footnotes
Reconciliation of Non-GAAP Financial Measures 1.) As a result of the sale of our merchant services business (the "Merchant Services Business"), which was completed on September 20, 2024, and the sale of our Healthcare revenue cycle management business (the "Healthcare RCM Business"), which was compl
Slide 8: Non-GAAP Adjusted Diluted EPS
Non-GAAP Adjusted Diluted EPS(1) The reconciliation of our GAAP diluted EPS from continuing operations and non-GAAP Adjusted diluted EPS from continuing operations for the current and prior year quarters are as follows: ($ in thousands, except share and per share amounts) Three Months Ended March 31
Slide 9: Non-GAAP Financial Measures Footnotes
Reconciliation of Non-GAAP Financial Measures 1.) Diluted net income (loss) per share attributable to Class A common stockholders from continuing operations and adjusted diluted earnings per share from continuing operations both exclude the discontinued operations of the Merchant Services Business a
Slide 10: Free Cash Flow
Reconciliation of Free Cash Flow The reconciliation of GAAP net cash provided by operating activities to non-GAAP Free Cash Flow is as follows: ($ in thousands) Three Months Ended December 31, September 30, June 30, 2026 March 31, 2026 2025 2025 Net cash provided by operating activities $ 14,264 $ 1